热门资讯> 正文
Align Technology就侵犯专利矫正器向美国贸易委员会提起投诉
2025-09-24 05:52
- Align Technology (NASDAQ:ALGN) has filed a Section 337 complaint with the U.S. International Trade Commission.
- The complaint targets Angelalign Technology, alleging unauthorized importation and sale of clear aligners that infringe Align’s patents.
- Align is seeking an exclusion order to block imports of infringing aligners into the U.S.
- The company also seeks a cease-and-desist order to stop the sale of already-imported infringing products.
- Source: Press release
More on Align Technology
- Align Technology, Inc. (ALGN) Presents At Baird Global Healthcare Conference 2025 Transcript
- Align Technology, Inc. (ALGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- Align Technology, Inc. (ALGN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
- Align Technology plunges on results miss, Morgan Stanley downgrade (update)
- Align Technology Q2 2025 Earnings Preview
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。